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Abstract
Background: The objective of this study is to assess the clinical significance and prognostic impact of extramural
metastasis in colorectal carcinoma and establish an optimal categorization in the staging system.
Methods: To determine the frequency and prognostic significance of extramural metastasis, from 2000 to 2005, a
total of 1,215 patients with colorectal cancer who underwent surgical resection were recruited into this study.
Individual demographic and clinicopathologic data were collected including tumor stage, nodal stage, tumor
histology, degree of tumor differentiation, and presence of lymphovascular invasion. After surgery, all patients
received standard treatments and follow-up, which were closed in April 2010.
Results: EM was detected in 167 (13.7%) patients and in 230 (1.8%) of the 12,534 nodules retrieved as ‘lymph
nodes’. The incidence of extramural metastasis was significantly higher in patients with large tumors, deeper
invasive depth and more lymph node metastasis (P < 0.001). After curative operation, overall survival was
significantly worse for patients with extramural metastasis than those without (P < 0.001). Multivariate analysis
identified extramural metastasis as an independent prognostic factor (RR = 2.1, 95%CI:1.5-3.0). By using the Akaike
information criterion (AIC), N staging was capable of predicting survival outcome with the highest accuracy when
both nodal involvement and extramural metastasis were treated together as N factors(AIC = 1025.3).
Conclusion: Extramural metastasis might be diagnosed as replaced lymph nodes in the process of classification,
thus forming a new categorization.
Keywords: extramural metastasis, staging, colorectal cancer
Background
Histologic examination of dissected nodal structures
may disclose the presence of nodules of tumors that are
not contained within recognizable lymph nodes. This
kind of cancer deposit called Extramural Metastasis
(EM), is found during routine examination of about 10-
20 percent of resected gastric carcinoma specimens [1]
and 15-50 percent of colorectal carcinoma specimens
[2,3]. The presence of EM has also been identified as a
prognostic factor [2], but whether the EM should be
treated as equal to other traditional prognostic factors is
still unknown.
The TNM classification is used worldwide for cancer
staging. It’s important that the patients’ treatment and
prognosis be followed and built upon this classification.
EM may be either small lymph nodes or lymphoid
aggregates that have been totally replaced by a tumor or
discontinuous foci of a tumor within a pericolonic,
extranodal, perivascular or intravascular location [4]. It
is unclear whether EM should be categorized into pT
staging, pN staging or excluded from consideration in
determining tumor stage. Based on the 5
th edition TNM
Classification of Malignant Tumors [5], a tumor nodule
greater than 3 mm in diameter is classified in the N
category as lymph node metastasis. The 6
th edition of
the TNM classification [6] recognizes the heterogeneity
of these lesions and suggests that they be classified as
positive lymph nodes if they occur in the connective tis-
sue of a lymph drainage area and have the form and
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lar contour, then they should be classified under T as a
discontinuous extramural extension. However, some
challenge this because they believe size should not affect
the diagnosis of metastatic cancer and that tumor foci
which show evidence of growth(eg. glandular differentia-
tion, distension of sinus, or stromal reaction) should be
diagnosed as a lymph node metastasis regardless of size
[7]. Recently, the 7
th edition of the TNM classification
has been modified such that the extramural tumor
deposits found in patients with T1 and T2 lesions be
classified as N1c disease [8], but it is still unclear how
to stage the EM for patients with T3 or T4. To date,
few studies have discussed the significance of the EM
through convincing analysis in colorectal cancer, and
there are even less data on the optimal categorization of
such foci. Nevertheless, an optimal categorization should
heighten the value of the TNM classification as a prog-
nostic grading system.
Therefore, the aim of the present study is to assess the
incidence and extent of EM in patients with colorectal
cancer. Furthermore, its relation to other clinicopatholo-
gic factors was studied and its prognostic significance
was analyzed. To resolve the question of their origin, we
classified them into several different stages based on our
provisional definition of the EM and determined
whether EM should be categorized in the prognostic
staging system, providing useful prognostic information
to optimize the TNM classification.
Methods
Patients
In this retrospective study, data were collected from the
medical records of 1,215 patients who underwent resec-
tion for colorectal cancer at the Sun Yat-Sen University
Cancer Center in Guangzhou, China, from January 2000
to December 2005. To be eligible for the study, patients
were required to have pathologically confirmed colorec-
tal carcinoma and had more than 12 lymph nodes from
surgical specimens. All patients underwent standard seg-
mental colectomy and regional lymphadenectomy. Indi-
vidual demographic and clinicopathologic data were
collected including tumor stage, nodal stage, tumor his-
tology, degree of tumor differentiation, and presence of
lymphovascular invasion. The protocol was approved by
our institutional review board in keeping with Chinese
bioethical regulations. All patients gave a written
informed consent before participating in the study.
EM was defined as the presence of cancer cells in soft
tissue that was discontinuous with the primary lesion or
in peri-bowel soft tissue distinct from the lymph node.
Lymph nodes and EM were identified and retrieved
from formalin-fixed surgical specimens without using
any specific technique to increase the nodal retrieval
rate. Paraffin-embedded specimens were stained with
haematoxylin and eosin, and examined microscopically
for metastases. All cases with clolorectal cancer were
subsequently step-sectioned, resulting in a total of
119,070 slides, which were H&E stained and systemati-
cally screened by 2 pathologists independently. No spe-
cial immunohistochemical techniques were used to
identify micrometastases.
Treatment
Eligible patients had completely resected primary color-
ectal adenocarcinoma. The staging was according to
AJCC Cancer Staging Manual 6
th edition [6]; Based on
this staging, all the patients who need adjuvant che-
motherapy received the 5-FU-based regimen, and the
basic regimen was FOLFOX6 or XELOX. The patients
with rectal cancer received prior chemotherapy or radio-
therapy and the patients with post-operative metastasis
underwent palliative treatments (including chemother-
apy, surgical resection and radio frequency ablation)
according to the updated NCCN guideline for Colorec-
tal cancer [9].
Follow up
After discharge from the hospital, all patients entered a
follow-up program according to standard protocol [10].
Within the first 2 years after surgery, a follow-up every
3 months consisted of a clinical examination, routine
blood tests, assessment of concentration of tumor mar-
kers, and abdominal ultrasonography or CT scan; endo-
scopy was done every 6 months for the first 2 years
after surgery. In addition, for the next 3 years, patients
were followed up every 6 months and underwent endo-
scopy every 12 months. At relapse (defined as local
recurrence or metastasis at distant sites), all patients
were staged fully to detect disease at other sites. The
follow-up was closed in April 2010.
Statistical Analysis
In this study, all patients had been retrospectively reclas-
sified into different stages according to AJCC Cancer
Staging Manual 7
th edition. Mann-Whitney U and c2
tests were used where appropriate to compare the distri-
bution of individual variables between groups. Overall
survival (OS) and Disease-free survival(DFS) curves were
calculated by Kaplan-Meier method and the differences
between 2 groups were compared by log-rank test. The
probability for entering the model was 0.05 and that for
removal from the model was 0.100. Multivariable analy-
sis was performed using a Cox proportional hazards
model with an enter procedure. A two-tailed p value of
less than 0.05 was considered statistically significant.
The Akaike Information Criterion (AIC) [11] was used
to identify the optimal categorization of EM that
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mination of survival outcome. The AIC (AIC = -2 × Log
Likelihood + 2 × No. of Parameters in the Model) is an
e s t i m a t eo ft h em e a s u r eo ff i to fam o d e lt oag i v e ns e t
of data. The model of choice achieves parsimony with
maximum likelihood and is the one with the lowest
value of AIC, indicating the smallest loss of information
for predicting outcome [12]. Statistical analysis was per-
formed with SPSS for Windows V.13.0.
Results
The study consisted of 695 men and 520 women, the
median age was 58 years (range 18-85). Stage distribu-
tion included 210(17.3%) patients with stage I, 395
(32.5%) patients with stage II, 336(27.7%) with stage III
and 274(22.6%) with stage IV. Overall, EM(Figure 1) was
detected in 167 (13.7%) of the 1215 patients and in 230
(1·8%) of the 12,534 nodules retrieved as ‘lymph nodes’.
In the 167 patients with EM, the mean number of
metastases of this type was 1.4 (median 1, range 1-5).
Figure 1 shows an example of EM.
The incidence of EM was significantly higher in
patients with large tumors (diameter 5 cm or more) and
in those with macroscopic infiltrative tumors. Histologi-
cally, the incidence of EM had positive correlation with
tumor penetration depth and lymph node metastasis,
which were determined by leaving the existence of EM
out of the calculation. Patients with EM had significantly
deeper tumor invasion and larger number of lymph
node metastases; in addition, peritoneal dissemination
was found more frequently at surgery in patients with
EM (Table 1).
936 (77.0%) of all patients and 112 (67.0%) of 167
patients with EM underwent curative surgery. After a
potentially curative procedure, 66(58.9%) of 112 patients
with EM experienced recurrence, compared with 187
(22·6%) of 824 patients without EM. Of those classified
as EM, 23 patients (34.8%) had recurrence locally or in
the lymph nodes, 21 patients (31.8%) had hepatic invol-
vement and 16 (24,2%) had peritoneum metastases. The
primary site of recurrence was unknown in 6 patients.
Regarding survival, analysis was performed in 936
patients who underwent potentially curative resection;
traditional prognostic variables such as the pT, pN,
tumor differentiation and tumor site correlated well
with the patients’ life expectation (Table 2), with tumor
stage according to the TNM system being a strong pre-
dictor of survival. A correlation with poorer clinical out-
come was also noted for poorly differentiated and
rectum location (data not shown). In the multivariate
analysis, EM emerged as an independent prognostic fac-
tor for survival (Table 2) together with the aforemen-
tioned factors. A positive EM at any site was
significantly associated with a shorter survival time (Fig-
ure 2a). Analysis of patients grouped according to the
number of EMs revealed that the number of metastases
was significantly associated with an even worse prog-
nosis (P < 0·001) (Figure 2b).
Different survival outcomes based on the N stage (N0,
N1, and N2) and the T stage (T1, T2, T3 and T4) were
compared among the following 3 definitions of the N
and T categories: A, 7
th edition the TNM definition
without considering EM; B, 7
th edition the TNM defini-
tion with EM considered as a T factor (T3 or T4); C,
7
th edition the TNM definition with EM considered a N
factor (Table 3).
According to the value of AIC, for the N stage, the
definition that both distinct nodal involvement and EM
were treated as N factors has the lowest ability(AIC =
1025.3) under the condition of using the 7th edition
A  1 0 0                             B  400 
Figure 1 Haematoxylin and eosin staining shows extramural metastasis in colorectal carcinoma. Tumor cells are scattered into the peri-
bowel soft tissue distinct from the metastatic lymph node. A Original magnification × 100, B × 400.
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group that EM were treated as pT3 or pT4, is the smal-
lest(AIC = 1089.7), which means it provided the best
prognostic T staging. The AIC in the group that has
both distinct nodal involvement and EM treated as N
factors also has a good value (AIC = 1090.9). Distribu-
tion and 5-year survival rate of 936 patients based on
the EM stratified into 3 different categories is summar-
ized in Figure 3; the difference in 5-year survival
between these defined groups was not great, and the dif-
ferences in the survival between different T staging
under the aforementioned provisional definitions were
much less than those between the values of the N stage.
Discussion
In this retrospective study, we investigated the clinical
parameters and the prognostic value of EM in a group
of patients who underwent surgical resection for color-
ectal carcinoma. The main findings are the following:
(1) the presence of EM had a significant correlation
with the primary tumor size, invasive depth and lymph
node metastasis; (2) the patients with EM had a higher
risk of peritoneal metastasis, EM is an independent
prognostic factor for all colorectal cancer patients, and
the patients with EM had a very poor clinical outcome;
and (3) EM may be regarded as lymph nodes in the pro-
cess of classification using 7
th AJCC Cancer Staging
Manual.
Metastatic status determines prognosis and indication
for adjuvant chemotherapy in patients with colorectal
cancer [13]. A recent population-based study in the Uni-
ted States concluded that, in 2001, most patients with
colorectal cancer received inadequate evaluation [14].
There is, thus, an important risk of understaging that
may exclude patients from postoperative chemotherapy,
a treatment with proven benefits in colon cancer with
advanced stage [15]. The existence of isolated tumor
deposits in the mesorectum was well demonstrated by
microscopic examination with serial transverse sections
of the mesorectum made as reported by Scott et al [16]
and Reynolds et al [17]. In routine practice, such tumor
deposits are observed in specimens sent for pathologic
examination as “lymph nodes.” T h e r ei sf e ws t u d yf o c u s
on these kinds of “lymph nodes” without lymph node
structure. The present study comprised patients with
colorectal cancer who underwent surgical resection. We
found that the presence of EM was about 15%, which
was associated with a larger tumor size, deeper invasion
depth and more positive nodes; this finding showed a
close correlation with cancer aggressiveness measured in
terms of serosal invasion. It has clinical significance as a
strong prognostic indicator independent of tumor depth
or nodal involvement in patients with colorectal cancer
who underwent operation, though we cannot neglect
the effect of EM on the survival outcome in the patients
with colorectal cancer.
In the incidence of peritoneal metastasis found during
surgery in patients with EM, our results were similar to
Etoh et al. [2]. There are two possible explanations for
Table 1 Correlation between EM and clinicopathological
features in Colorectal Cancer
Factors Extramural Metastasis(EM) P-value
Positive
(n = 167,%)
Negative
(n = 1,048,%)
Age(years) 0.093
< 58 94(56.3) 520(49.6)
≥58 73(43.7) 528(50.4)
Gender 0.677
Male 98(58.7) 597(57.0)
Female 69(41.3) 451(43.0)
Tumor size 0.003
< 5 cm 88(52.7) 676(64.5)
≥ 5 cm 79(47.3) 372(35.5)
Location 0.100
Colon 73(43.7) 530(50.6)
Rectum 94(56.3) 518(49.4)
Differentiation 0.411
Well 16(9.6) 89(8.5)
Moderately 111(66.5) 754(71.9)
Poorly 40(24.0) 205(19.6)
Invasive Depth < 0.001
T1 3(1.8) 58(5.5)
T2 19(11.4) 195(18.6)
T3 45(26.9) 339(32.3)
T4 100(59.9) 456(43.5)
Lymph Node Metastasis < 0.001
N0 71(42.5) 626(59.7)
N1 55(32.9) 266(25.4)
N2 41(24.6) 154(14.7)
Peritoneal metastasis 0.032
Yes 21(12.6) 80 (7.6)
No 146(87.4) 968(92.4)
Liver metastasis 0.232
Yes 27(16.2) 134(12.8)
No 140(83.8) 914(87.2)
Table 2 Univariate and multivariate Cox proportional
hazard model
Variable Univariate Multivariate
P Value RR 95%CI P Value RR 95%CI
EM < 0.001 2.4 1.8-3.3 < 0.001 2.1 1.5-3.0
Tumor site < 0.001 1.5 1.1-1.9 0.027 1.4 1.0-1.8
Differentiate 0.007 1.5 1.1-2.0 0.044 1.4 1.0-1.8
pT stage 0.002 1.3 1.1-1.5 0.033 1.3 1.1-1.5
pN stage < 0.001 2.0 1.7-2.4 < 0.001 1.7 1.4-2.0
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First, it is feasible that tumor cells released from a pri-
mary lesion spread directly into the extranodal and
extramural spaces [1,18]. Another possibility is that EM
occurs subsequent to lymph node involvement. Takata
et al. [1] found that the occurrence of lymph node
metastasis was high in patients with peritoneal metasta-
sis. EM was associated with peritoneal metastasis, which
is one of the most important prognostic factors in this
tumor type; the patients with EMs had a shorter OS and
D F S .T h em u l t i v a r i a t ea n a l y s i ss h o w st h a tE Mi sa n
independent prognostic factor along with pT, pN sta-
ging, tumor site and tumor differentiation. In addition,
the numbers of EMs have an important role in the esti-
mation of postoperative survival. The existence of 3 or
more EMs might have a poorer prognostic impact than
those with 1-2 deposits of EM; in the present study, 3
or more EMs were found in 4.3% of patients who had
undergone curative resection of colorectal cancer and
related to an unfavorable 5-year survival rate of 18.0%.
Our findings confirming that EM is a negative prognos-
tic factor for advanced colorectal adenocarcinoma are
helpful to those clinicians in need of a staging system
which emphasizes the prognostic heterogeneity of
patients within the same tumor stage group. The differ-
ent prognostic implications of EM could well be
incorporated into new staging proposals. It is very
important to determine whether EM should be treated
as an N factor or as a T factor in a prognostic staging
system, so that the clinician can more conveniently pro-
vide an accurate classification.
We compared 3 staging systems with different cate-
gorizations of EM, including categorizations based on
the TNM classifications of the 7th editions in terms of
their discriminatory power with regard to survival out-
come. In our analysis, we used the AIC which can be
used to identify the optimal categorization of an out-
come variable and to compare systems with different
combinations of variables [19], although in the differ-
ence in the 5-year survival rate of patients classified
according to the various staging systems shown in Fig-
u r e3 ,w ef o u n dt h a tt h ev a l u eo fA I Cw a ss m a l l e s t
when both distinct nodal involvement and EM were
treated as N factors. We still note that there was little
difference in the AIC value among the T staging systems
analyzed, and it could be said that the classification of
EM exerts little influence on the clinical significance of
the T stage because of the low incidence of EM in T1
and T2 cases, which indicated that the EM might be
treated as an N factor defined by the TNM 7th edition.
To our knowledge, our results initially report this new
categorization.
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Figure 2 Survival analysis of EM in patients with colorectal cancer. A: Prognostic significance of Extramural Metastasis(EM) on Disease-Free
Survival(DFS) of the CRC patients underwent curative surgery(p < 0.001), B: DFS curves of CRC patients stratified by EM number (0, 1-2, ≥3) (p <
0.001).
Table 3 Definitions of N and T Categories and Their Impact on the Prognostic Value of N and T Staging Systems
Definition EM Classified into N and T Categories N Staging T Staging
N T AIC HR (95% CI) AIC HR (95% CI)
A TNM classification (7th ed) 1040.2 2.37(1.92-2.92) 1094.1 1.36(1.15-1.60)
B Distinct nodal involvement EM for (T3 or T4) 1040.2 2.37(1.92-2.92) 1089.7 1.42(1.20-1.68)
C 1.Distinct nodal involvement pT staging 1025.3 2.65(2.15-3.27) 1090.9 1.37(1.15-1.61)
2.EX
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patients shows little difference from other various sta-
ging systems (Figure 3), but the clinically most beneficial
staging system is one that assigns as many patients as
possible to the most favorable or most unfavorable stage
when survival outcome of patients classified in the same
stage is the same [20]. Ueno et al. in 2007 [21] proposed
that N staging was capable of predicting survival out-
come with the highest accuracy when both nodal invol-
vement and non-vascular invasion-type (non-VAS) were
treated together as an N factor and VAS was treated as
aTf a c t o r ,b u tt h eu s eo ft h es u b j e c t i v ed e s c r i p t i o n
form and smooth contour of a lymph node may lead to
inappropriate upstaging [7]. The current dilemma can
be traced to 2 facts: (1) the historical precedent of pla-
cing too much reliance on an unnecessary limited set of
prognostic variables (eg, lymph node status) for the pur-
poses of stratifying patients and making therapeutic
decision and (2) the impossibility of determining the
actual nature of a high proportion of mesenteric depos-
its [4,7]. Herein we took both of these factors into
account and recommend that in situations in which
small mesenteric and perirectal tumor deposits might be
diagnosed as lymph nodes, the total number and the
size of the largest deposits should be recorded and the
clinician be made aware that these lesions are likely to
be associated with an adverse prognosis.
Conclusion
These results suggest that standard pathologic examina-
tion underestimates the number of metastases in meso-
colon specimens from colorectal cancer patients by
failing to detect not only small involved nodes but also
extramural metastases. Routine pathologic examination
should focus on these foci of cancer metastasis and help
to refine the staging of patients with colorectal cancer.
A: 7
th  TNM  classification              B:  EM  was  categorized  into  pT  staging 
C:  EM  was  categorized  into  pN  staging        
 
5-Year Survival Rate (%) 
  A  B  C 
I  88  90  88 
II  78  78  78 
III  62  62  62 
IV  27  27  27 
Figure 3 Distribution and 5-year survival rate of 936 patients based on the EM stratified into four different categories.A :7 t hT N M
classification, B: EM was categorized into pT staging, C: EM was categorized into pN stagin.
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fication, together with the classic prognostic factors, will
provide a more accurate classification, benefit adjuvant
chemotherapy for patients and assess more exact prog-
nostic information.
Acknowledgements
The authors acknowledge all medical personnel of the department of
abdominal surgery for their help
Grant Support
Supported by National Natural Science Foundation (30672408)
Author details
1State Key Laboratory of Oncology in South China, Guangzhou, Guangdong,
510060, P. R. China.
2Department of Medical Oncology, Sun Yat-sen
University Cancer Center, Guangzhou, Guangdong, 510060, P. R. China.
3Department of Gastric & Pancreatic Surgery, Sun Yat-sen University Cancer
Center, Guangzhou, Guangdong, 510060, P. R. China.
4Department of
Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou,
Guangdong, 510060, P. R. China.
5Department of Pathology, Sun Yat-sen
University Cancer Center, Guangzhou, Guangdong, 510060, P. R. China.
Authors’ contributions
The work presented here was carried out in collaboration between all
authors. RHX and ZZW defined the research theme and research methods.
HBQ and GC co-worked on associated data collection, interpretation and
discussed analyses and wrote the paper, RPK revised the manuscript, HYL
and MZQ analyzed the data and interpreted the results. FW evaluated the
pathological data. All authors have contributed to, seen and approved the
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 11 December 2010 Accepted: 26 September 2011
Published: 26 September 2011
References
1. Tanaka T, Kumagai K, Shimizu K, Masuo K, Yamagata K: Peritoneal
metastasis in gastric cancer with particular reference to lymphatic
advancement; extranodal invasion is a significant risk factor for
peritoneal metastasis. J Surg Oncol 2000, 75(3):165-171.
2. Etoh T, Sasako M, Ishikawa K, Katai H, Sano T, Shimoda T: Extranodal
metastasis is an indicator of poor prognosis in patients with gastric
carcinoma. Br J Surg 2006, 93(3):369-373.
3. Wind J, ten Kate FJ, Kiewiet JJ, Lagarde SM, Slors JF, van Lanschot JJ,
Bemelman WA: The prognostic significance of extracapsular lymph node
involvement in node positive patients with colonic cancer. Eur J Surg
Oncol 2008, 34(4):390-396.
4. Goldstein NS, Turner JR: Pericolonic tumor deposits in patients with T3N
+MO colon adenocarcinomas: markers of reduced disease free survival
and intra-abdominal metastases and their implications for TNM
classification. Cancer 2000, 88(10):2228-2238.
5. Fleming ID, C J, H D, Hutter RVP, et al: AJCC Cancer Staging Manual.
Philadelphia: Lippincott-Raven;, 5 1998.
6. Greene F, PD FI, Fritz A: AJCC Cancer Staging Manual. New York: Springer-
Verlag;, 6 2002.
7. Jass JR, O’Brien MJ, Riddell RH, Snover DC: Recommendations for the
reporting of surgically resected specimens of colorectal carcinoma. Hum
Pathol 2007, 38(4):537-545.
8. Sobin Leslie, G M, W C: TNM classification of malignant tumours. New
York: Wiley-Blackwell;, 7 2009.
9. Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS,
Covey A, Dilawari RA, Early DS, Enzinger PC, et al: NCCN Clinical Practice
Guidelines in Oncology: colon cancer. J Natl Compr Canc Netw 2009,
7(8):778-831.
10. Desch CE, Benson AB, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL,
Minsky BD, Pfister DG, Virgo KS, Petrelli NJ: Colorectal cancer surveillance:
2005 update of an American Society of Clinical Oncology practice
guideline. J Clin Oncol 2005, 23(33):8512-8519.
11. Akaike H: Information theory and an extension of the maximum
likelihood principle. In Proceedings of the Second International Symposium
on Information Theory. Edited by: Petrov BC. Budapest, Hungary: Akademia
Kiado; 1973:267-281.
12. Wunder JS, Healey JH, Davis AM, Brennan MF: A comparison of staging
systems for localized extremity soft tissue sarcoma. Cancer 2000,
88(12):2721-2730.
13. Zaniboni A, Labianca R: Adjuvant therapy for stage II colon cancer: an
elephant in the living room? Ann Oncol 2004, 15(9):1310-1318.
14. Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA:
Lymph node evaluation in colorectal cancer patients: a population-
based study. J Natl Cancer Inst 2005, 97(3):219-225.
15. NIH consensus conference. Adjuvant therapy for patients with colon
and rectal cancer. JAMA 1990, 264(11):1444-1450.
16. Scott N, Jackson P, al-Jaberi T, Dixon MF, Quirke P, Finan PJ: Total
mesorectal excision and local recurrence: a study of tumour spread in
the mesorectum distal to rectal cancer. Br J Surg 1995, 82(8):1031-1033.
17. Reynolds JV, Joyce WP, Dolan J, Sheahan K, Hyland JM: Pathological
evidence in support of total mesorectal excision in the management of
rectal cancer. Br J Surg 1996, 83(8):1112-1115.
18. Koike H, Ichikawa D, Kitamura K, Tsuchihashi Y, Yamagishi H: Perinodal
involvement of cancer cells in gastric cancer patients. Surgery 2004,
135(3):266-272.
19. Burnham KP, A D: Model selection and multimodel inference: a practical
information-theoretic approach. Colorado: Colorado Cooperative Fisher
and Wildlife Research Unit;, 2 2006.
20. Jass JR, Love SB, Northover JM: A new prognostic classification of rectal
cancer. Lancet 1987, 1(8545):1303-1306.
21. Ueno H, Mochizuki H, Hashiguchi Y, Ishiguro M, Miyoshi M, Kajiwara Y,
Sato T, Shimazaki H, Hase K: Extramural cancer deposits without nodal
structure in colorectal cancer: optimal categorization for prognostic
staging. Am J Clin Pathol 2007, 127(2):287-294.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2407/11/414/prepub
doi:10.1186/1471-2407-11-414
Cite this article as: Qiu et al.: The extramural metastasis might be
categorized in lymph node staging for colorectal cancer. BMC Cancer
2011 11:414.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Qiu et al. BMC Cancer 2011, 11:414
http://www.biomedcentral.com/1471-2407/11/414
Page 7 of 7